+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharmaceuticals Market Research Reports

Autogenous Vaccines - Global Strategic Business Report - Product Thumbnail Image

Autogenous Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 266 Pages
  • Global
From
Digital Vaccines - Global Strategic Business Report - Product Thumbnail Image

Digital Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 274 Pages
  • Global
From
Pertussis Vaccines - Global Strategic Business Report - Product Thumbnail Image

Pertussis Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 285 Pages
  • Global
From
Plant-based Vaccines - Global Strategic Business Report - Product Thumbnail Image

Plant-based Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 390 Pages
  • Global
From
Allergy Vaccines - Global Strategic Business Report - Product Thumbnail Image

Allergy Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 481 Pages
  • Global
From
Respiratory Virus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Respiratory Virus Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 474 Pages
  • Global
From
Rubella Vaccines - Global Strategic Business Report - Product Thumbnail Image

Rubella Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 275 Pages
  • Global
From
Typhoid Fever Vaccines - Global Strategic Business Report - Product Thumbnail Image

Typhoid Fever Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 372 Pages
  • Global
From
Vaccine Technologies - Global Strategic Business Report - Product Thumbnail Image

Vaccine Technologies - Global Strategic Business Report

  • Report
  • November 2026
  • 573 Pages
  • Global
From
Toxoid Vaccines - Global Strategic Business Report - Product Thumbnail Image

Toxoid Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 282 Pages
  • Global
From
Rotavirus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Rotavirus Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 277 Pages
  • Global
From
From
From
Multivalent Vaccines - Global Strategic Business Report - Product Thumbnail Image

Multivalent Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 278 Pages
  • Global
From
Mumps Vaccines - Global Strategic Business Report - Product Thumbnail Image

Mumps Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 288 Pages
  • Global
From
Nasal Vaccines - Global Strategic Business Report - Product Thumbnail Image

Nasal Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 220 Pages
  • Global
From
From
Chickenpox Vaccines - Global Strategic Business Report - Product Thumbnail Image

Chickenpox Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 374 Pages
  • Global
From
Ebola Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ebola Drugs and Vaccines - Global Strategic Business Report

  • Report
  • November 2026
  • 485 Pages
  • Global
From
From
Loading Indicator

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders. Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively. Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more